Ceapro Inc - stock earnings

CZO.V Quarterly earnings

DateEarningsRevenue
2023Q3 -1.0 million CAD 2.6 million CAD
2023Q2 -1.2 million CAD 1.9 million CAD
2023Q1 -385050 CAD 3.5 million CAD
2022Q4 -122109 CAD 3.3 million CAD
2022Q3 861648 CAD 3.8 million CAD
2022Q2 1.7 million CAD 5.5 million CAD
2022Q1 2.0 million CAD 6.2 million CAD
2021Q4 775855 CAD 3.6 million CAD
2021Q3 875274 CAD 4.5 million CAD
2021Q2 676472 CAD 4.4 million CAD
2021Q1 514876 CAD 4.7 million CAD
2020Q4 -538617 CAD 2.7 million CAD
2020Q3 191623 CAD 3.5 million CAD
2020Q2 1.1 million CAD 4.7 million CAD
2020Q1 1.1 million CAD 4.3 million CAD
2019Q4 166105 CAD 3.7 million CAD
2019Q3 -103514 CAD 2.9 million CAD
2019Q2 -558591 CAD 3.1 million CAD
2019Q1 -636628 CAD 3.2 million CAD
2018Q4 444032 CAD 4.5 million CAD
2018Q3 -298669 CAD 2.1 million CAD
2018Q2 -165693 CAD 2.7 million CAD
2018Q1 -295207 CAD 2.3 million CAD
2017Q4 -1.6 million CAD 3.0 million CAD
2017Q3 295570 CAD 3.6 million CAD
2017Q2 370422 CAD 3.2 million CAD
2017Q1 17768 CAD 3.2 million CAD
2016Q4 125662 CAD 2.4 million CAD

CZO.V Yearly earnings

DateEarningsRevenue
2023 -2.8 million CAD 11.3 million CAD
2022 4.4 million CAD 18.8 million CAD
2021 2.8 million CAD 17.2 million CAD
2020 1.9 million CAD 15.1 million CAD
2019 -1.1 million CAD 12.9 million CAD
2018 -315537 CAD 11.6 million CAD
2017 -958275 CAD 12.9 million CAD
2016 3.6 million CAD 13.7 million CAD
2015 4.9 million CAD 10.7 million CAD
2014 1.6 million CAD 8.9 million CAD
2013 175808 CAD 6.5 million CAD

CZO.V

Price: CA$0.24

52 week price:
0.15
0.64

Earnings Per Share: -0.03 CAD

P/E Ratio: -5.83

Exchange: VAN

Sector: Healthcare

Industry: Biotechnology

Volume: 26500

Market Capitalization: 19.2 million

Links: